Target intelligence / Profile preview

RBM5 antisense RNA 1 (RBM5-AS1)

Target
RBM5-AS1
Molecular classification
Long non-coding RNA, Other
01

Overview

RBM5 antisense RNA 1 (RBM5-AS1), also known as LUST (LUCA-15-specific transcript), is a long non-coding RNA transcribed antisense to the RBM5 gene. It is predominantly localized in the nucleus and acts as a chromatin-associated regulatory RNA. RBM5-AS1/LUST is involved in the regulation of WNT/β-catenin signaling through direct interaction with β-catenin, promoting assembly of the β-catenin–TCF4 complex at WNT target gene promoters. This lncRNA is critical for maintaining stem-like characteristics and self-renewal of cancer-initiating cells in colon and breast cancer. Its expression correlates with tumor progression, maintenance of stemness, increased cell proliferation, resistance to differentiation, and poorer clinical outcome[1][2][4][5].

Other names
LUSTLUCA-15-specific transcriptLUST (LUCA-15-specific transcript)LUCA-15 specific transcript
02

Mechanism of action

Regulates WNT/β-catenin signaling by physically interacting with β-catenin and facilitating the β-catenin-TCF4 transcriptional complex, modulates transcription of WNT target genes (e.g., MYC, CCND1, YAP1, SGK1)[1][2][4][5]

03

Biological functions

Regulation of WNT/β-catenin signalingRegulation of gene expressionMaintenance of cancer stem cell-like propertiesPromotion of cell proliferationPromotion of cell survivalPromotion of cellular “stemness”Regulation of chromatin structure
04

Disease associations

Cancer, particularly colon cancer and breast cancer (stemness and tumorigenesis)Other solid tumors (evidence also in osteosarcoma, hepatoma, oral squamous cell carcinoma)
05

Biomarkers

Elevated RBM5-AS1/LUST expression is associated with poor prognosis and reduced survival in colorectal and possibly other cancers

Beyond the preview

Go deeper on RBM5 antisense RNA 1 (RBM5-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBM5 antisense RNA 1 (RBM5-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call